Why the study?
To evaluate the evidence for conservative and surgical management of neoplastic and idiopathic pericardial effusions in dogs.
Does conservative or surgical management improve outcomes in dogs with naturally occurring pericardial effusion?
Does conservative or surgical management improve outcomes in dogs with naturally occurring pericardial effusion?
There is currently insufficient high-quality evidence to recommend a specific conservative or surgical treatment option for pericardial effusion in dogs.
Insufficient evidence precludes specific treatment recommendations for canine pericardial effusion; leaves open the need for prospective standardized trials.
Objective To evaluate the evidence for the conservative and surgical management of pericardial effusions for neoplastic and idiopathic etiologies in dogs. Study design Systematic review. Sample population Peer‐reviewed English‐language articles describing the treatment and outcome of naturally occurring pericardial effusion in domestic dogs. Methods A literature search was performed with PubMed, Cab Abstracts, Scopus, and Agricola in August 2019 for articles describing pericardial effusion treatment in dogs. Inclusion criteria were applied, and articles were evaluated for reported outcome and level of evidence by using The Oxford 2011 Levels of Evidence, a previously described hierarchical system, and GRADE (Grading of Recommendations, Assessment, Development and Evaluation). Results One hundred eight of the 641 unique articles that were identified and evaluated met inclusion criteria. Most articles included were case studies (68.2%) or retrospective case series (25.2%), with all articles providing a low level of evidence. The articles had inconsistent inclusion criteria, outcome measures, and follow‐up, making comparison of outcomes difficult. Conclusion Because of the low quality of evidence of the studies included in this systematic review and the variability of the outcomes, there is not sufficient evidence to recommend one treatment option rather than another. Clinical significance There is a requirement for higher quality evidence such as randomized controlled trials and prospective comparative cohort studies. Standardization of outcome measures reported for each treatment option and disease process studied will allow for better comparison of outcomes between studies.
No takes yet. Share an insight, caveat, or question.
Scheuermann et al. (2020) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: